The cardiac pacemaker lead is a relatively fragile cable of insulated conductor wire implanted into the hostile environment of the human body. Its function is to interface the power source and sophisticated electronics of the pulse generator with the heart. The pacemaker lead plays a critical role in delivering both the output pulse from the pulse generator to the myocardium and the intracardiac electrogram from the myocardium to the sensing circuit of the pulse generator.


Pulse Generator Silicone Rubber Tissue Interface Stimulation Threshold Pace Lead 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mond H, Irwin M, Morillo C et al.: The World survey of cardiac pacing and cardioverter defibrillators: Calendar year 2001. PACE 2004; 27:955–964.PubMedGoogle Scholar
  2. 2.
    Mond HG: Unipolar versus bipolar pacing - Poles apart. PACE 1991; 14:1411–1424.PubMedGoogle Scholar
  3. 3.
    Griffin JC: Sensing characteristics of the right atrial appendage electrode. PACE 1983; 6:22–25.PubMedGoogle Scholar
  4. 4.
    Mond H. and Barold SS: Dual chamber, rate-adaptive pacing in patients with paroxysmal supraventricular tachyarrhythmias: Protective measures for rate control. PACE 1993; 16:2168–2185.PubMedGoogle Scholar
  5. 5.
    Mymin D, Cuddy TE, Sinha SN, et al.: Inhibition of demand pacemakers by skeletal muscle potentials. JAMA 1973; 223:527–532.CrossRefGoogle Scholar
  6. 6.
    Cameron J, Ciddor G, Mond H, et al.: Stiffness of the distal tip of bipolar pacemaker leads. PACE 1990: 13;1915–1920.PubMedGoogle Scholar
  7. 7.
    Kistler PM, Eizenberg N, Fynn SP et al.: The subpectoral pacemaker implant: It isn’t what it seems! PACE 2004; 27:361–364.PubMedGoogle Scholar
  8. 8.
    Weiss DN, Zilo P, Luceri RM et al.: Should unipolar pacemaker leads be banned? Lessons from pacemaker/implantable cardioverter defibrillator interactions. PACE 1997; 20:237–239.PubMedGoogle Scholar
  9. 9.
    Mond H: The Cardiac Pacemaker. Function and Malfunction. New York: Grune and Stratton, 1973, pp. 60–66.Google Scholar
  10. 10.
    Schuchert A and Kuck KH: Influence of internal current and pacing current on pacemaker longevity. PACE 1994; 17:13–16.PubMedGoogle Scholar
  11. 11.
    Ellenbogen KA, Wood MA, Gilligan DM, et al.: Steroid eluting high impedance pacing leads decrease short and long term current drain: Results from a multicenter clinical trial. PACE 1999; 22:39–48.PubMedGoogle Scholar
  12. 12.
    Parsonnet V, Gilbert L, Lewin G et al.: A non polarizing electrode for endocardial stimulation of the heart. J Thorac Cardiovasc Serg. 1968; 56:710–715.Google Scholar
  13. 13.
    Schaldach M, Hubman M, Weikl A, et al.: Sputter-deposited TiN electrode coatings for superior sensing and pacing performance. PACE 1990; 13:1891–1895.PubMedGoogle Scholar
  14. 14.
    Elmqvist H, Schueller H, Richter G: The carbon tip electrode. PACE 1983; 6:436–439.PubMedGoogle Scholar
  15. 15.
    Moracchini PV, Cappelletti F, Melandri PF, et al.: Titanium oxide tip electrode, A solution to minimize polarization and threshold increase (Abstract). PACE 1985; 8:A–85.Google Scholar
  16. 16.
    Schaldach M, Hubman M, Weikl A, et al.: Sputter-deposited TiN electrode coatings for superior sensing and pacing performance. PACE 1990; 13:1891–1895.PubMedGoogle Scholar
  17. 17.
    Tang C, Yeung-Lai-Wah JA, Qi A, et al.: Initial experience with a co-radial bipolar pacing lead. PACE 1997; 20:1800–1807.PubMedGoogle Scholar
  18. 18.
    DelBufalo AGA, Schlaepfer J, Fromer M et al.: Acute and long-term ventricular stimulation thresholds with a new, Iridium oxide-coated electrode. PACE 1993; 16:1240–1244.Google Scholar
  19. 19.
    Mond H and Stokes KB: The electrode–tissue interface: the revolutionary role of steroid elution. PACE 1992; 15:95–107.PubMedGoogle Scholar
  20. 20.
    Sibille Y and Reynolds H: Macrophages and polymorphonuclear neutrophils in lung defence and injury. Am Rev Respir Dis 1990; 41:471–501.Google Scholar
  21. 21.
    Guerola M and Lindegren U: Clinical evaluation of membrane-coated 3, 5 mm2 porous titanium nitride electrodes. In Aubert AE, Ector H and Stroobandt R (eds). Euro-pace’93 Monduzzi Editore, 1993, pp. 447–450.Google Scholar
  22. 22.
    Stokes K, Bornzin G: The electrode - biointerface: Stimulation. In Barold SS (ed). Modern Cardiac Pacing. New York: Futura Publishing, 1985, pp. 33–77.Google Scholar
  23. 23.
    Brewer G, McAuslan BR, Skalsky M, et al.: Initial screening of bio-active agents with potential to reduce stimulation threshold (Abstract). PACE 1988; 11:509.Google Scholar
  24. 24.
    Kruse IM: Long-term performance of endocardial leads with steroid-eluting electrodes. PACE 1986; 9:1217–1219.PubMedGoogle Scholar
  25. 25.
    Mond HG: Development of low stimulation-threshold, low-polarization electrodes. In: New Perspectives in Cardiac Pacing. 2. Barold SS and Mugica J (eds). Mount Kisco, NY: Futura Publishing Company, Inc., 1991, P133–162.Google Scholar
  26. 26.
    Pioger G: Low surface area electrodes: comparison between Synox 60 BP (1.3 mm2), Capsure Z 5034 (1.2 mm2) and Stela BT26 (2 mm2):158 cases (Abstract). PACE 1997; 20:1443.Google Scholar
  27. 27.
    Hua W, Mond HG, and Strathmore N: Chronic steroid eluting lead performance: A comparison of atrial and ventricular pacing. PACE 1997; 20:17–24.PubMedGoogle Scholar
  28. 28.
    Till JA, Jones S, Rowland E, et al.: Clinical experience with a steroid eluting lead in children. Circulation 1989; 80:II–389.Google Scholar
  29. 29.
    Stokes K, Church T: The elimination of exit block as a pacing complication using a transvenous steroid eluting lead (Abstract). PACE 1987; 10:748.Google Scholar
  30. 30.
    Hiller K, Rothschild JM, Fudge W et al.: A randomized comparison of a bipolar steroid-eluting lead and a bipolar porous platinum coated titanium lead (Abstract). PACE 1991; 14:695.Google Scholar
  31. 31.
    Mond HG, Hua W and Wang CC: Atrial pacing leads: the clinical contribution of steroid elution. PACE 1995; 18:1601–1608.PubMedGoogle Scholar
  32. 32.
    Hua W, Mond H and Sparks P: The clinical performance of three designs of atrial pacing leads from a single manufacturer: the value of steroid elution. Eur J.C.P.E 1996; 6:99–103.Google Scholar
  33. 33.
    Stokes KB: Preliminary studies on a new steroid eluting epicardial electrode. PACE 1988; 11:1797–1803.PubMedGoogle Scholar
  34. 34.
    Karpawich PP, Hakimi M, Arciniegas E: Improved chronic epicardial pacing in children: Steroid contribution to porous platinised electrodes. PACE 1992; 15:1151–1157.PubMedGoogle Scholar
  35. 35.
    Mathivanar R, Anderson N, Harman D et al.: In vivo elution of drug eluting ceramic leads with a reduced dose of dexamethasone sodium phosphate. PACE 1990; 13:1883–1886.PubMedGoogle Scholar
  36. 36.
    Schuchert A, Kuck KH: Benefits of smaller electrode surface area (4 mm2) on steroid eluting leads. PACE 1991; 14:2098–2104.PubMedGoogle Scholar
  37. 37.
    Kistler PM, Liew G and Mond HG: Long-term performance of active-fixation pacing leads: a prospective study. PACE 2006; 29:226–230.PubMedGoogle Scholar
  38. 38.
    Kistler PM, Kalman JM, Fynn SP et al.: Rapid decline in acute stimulation thresholds with steroid-eluting active fixation pacing leads. PACE 2005; 28:903–909.PubMedGoogle Scholar
  39. 39.
    Anderson N, Mathivanar R, Skalsky M et al.: Active fixation leads–long term threshold reduction using a drug-infused ceramic collar. PACE 2004; 14:1767–1771.Google Scholar
  40. 40.
    Singarayar S, Kistler PM, DeWinter C et al.: A comparative study of the action of dexamethasone sodium phosphate and dexamethasone acetate in steroid-eluting pacemaker leads. PACE 2005; 28:311–315.PubMedGoogle Scholar
  41. 41.
    Bergdahl L: Helifix, an electrode suitable for transvenous and ventricular implantation. J Thorac Cardiovasc Surg 1980; 80:794–799.PubMedGoogle Scholar
  42. 42.
    Sloman JG, Mond HG, Bailey B et al.: The use of balloon-tipped electrodes for permanent cardiac pacing. PACE 1979; 2:579–585.PubMedGoogle Scholar
  43. 43.
    Mond H and Sloman G: The small-tined pacemaker lead–Absence of dislodgement. PACE 1980; 3:171–177.PubMedGoogle Scholar
  44. 44.
    Gammage MD, Swoyer J, Moes R et al.: Initial experience with a new design parallel conductor, high impedance, steroid-eluting bipolar pacing lead (Abstract). PACE 1997; 20:1229.Google Scholar
  45. 45.
    Tang C, Yeung-Lai-Wah JA, Qi A, et al.: Initial experience with a co-radial bipolar pacing lead. PACE 1997; 20:1800–1807.PubMedGoogle Scholar
  46. 46.
    Byrd CL, McArthur W, Stokes K et al.: Implant experience with unipolar pacing leads. PACE 1983; 6:868–882.Google Scholar
  47. 47.
    Scheuer-Leeser M, Irnich W, Kreuzer J: Polyurethane leads: facts and controversy. PACE 1983; 6:454–458.PubMedGoogle Scholar
  48. 48.
    Timmis GC, Westveer DC, Martin R et al.: The significance of surface changes on explanted polyurethane pacemaker leads. PACE 1983; 6:845–857.PubMedGoogle Scholar
  49. 49.
    Stokes K, Urbanski P, Upton J: The in vivo auto-oxidation of polyether polyurethanes by metal ions. J Biomatr Sc, Polym 1990; 1:207.CrossRefGoogle Scholar
  50. 50.
    Medtronic family of Novus® Leads. Medtronic, Minneapolis, MN.Google Scholar
  51. 51.
    Morgan K, Bornzin GA, Florio J et al.: A new single pass DDD lead (Abstract). PACE 1997; 20:1211.Google Scholar
  52. 52.
    Hirschberg J, Ekwall C and Bowald S: DDD pacemaker system with single lead (SLDDD) reduces intravascular hardware. Long-term experimental study (Abstract). PACE 1996; 19:601.Google Scholar
  53. 53.
    DiGregorio F, Morra A, Bongiorni M et al.: A multicenter experience in DDD pacing with single-pass lead (Abstract). PACE 1997; 20:1210.Google Scholar
  54. 54.
    Hartung WM, Strobel JP, Taskiran M, et al.: “Overlapping bipolar impulse”–Stimulation using a single lead implantable pacemaker system first results (Abstract). PACE 1996; 19:601.Google Scholar
  55. 55.
    Lucchese F, Halperin C, Strobel J et al.: Single lead DDD pacing with overlapping biphasic atrial stimulation–First clinical results (Abstract). PACE 1996; 19:601.Google Scholar
  56. 56.
    Vohra J, Hamer A, Mond H, Sloman G, Hunt D: Patient initiated implantable pacemakers for paroxysmal supraventricular tachycardia. Aust N Z J Med 1981; 11:27–34.PubMedGoogle Scholar
  57. 57.
    Leclercq C, Cazeau S, Le Breton H et al.: Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. JACC 1998; 32:1825–1831.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Harry G. Mond
    • 1
  1. 1.Cardiology DepartmentThe Royal Melbourne HospitalMelbourneUSA

Personalised recommendations